Antibiotics

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #iiCON: Infection Innovation Consortium #UK Health Security Agency #UK Research and Innovation

New UK initiatives take on deadly antimicrobial resistance

Two new UK funding initiatives will support the development of new antimicrobials and novel technology solutions to tackle infection transmission as part of an overall focus on antimicrobial resistance (AMR). In the first of these, PACE (Pathways to Antimicrobial Clinical Efficacy) has agreed a partnership with… Read More

#News

Bacteria
#Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Bacteriophage #ETH Zurich

Swiss scientists identify a virus that kills dormant bacteria

Researchers have found a virus that kills dormant bacteria, a discovery that could help to combat infections that can’t be treated with antibiotics. For the first time, ETH Zurich researchers in Switzerland have isolated a bacteriophage from rotting plant material that can attack and kill bacteria… Read More

#Editor's Choice #News

Petri dish used for bacterial research
#AMR #Antibiotic resistance #Antibiotics #Harvard Medical School #Roche

Excitement over new antibiotics that can kill drug-resistant bacteria

A novel antibiotic class targeting a major global pathogen and threat to human health has been discovered by scientists from Roche and Harvard University (Cambridge, MA, US). In two studies published in Nature, the authors demonstrate that the new class of drug candidates can effectively target… Read More

#News #Trending News

MRSA
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Artificial intelligence (AI) #Deep learning #Massachusetts Institute of Technology

AI helps find first new antibiotic in 60 years

Massachusetts Institute of Technology (MIT) researchers have used deep learning to identify a new class of antibiotic candidates that can kill methicillin-resistant Staphylococcus aureus (MRSA). The study represents more good news in the battle against antimicrobial resistance, as researchers from Harvard University and Roche also recently announced… Read More

#News #Trending News

Obulytix team
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Artificial intelligence (AI) #Ghent University #Start-ups

University spin-off creates solution to antibiotic resistance

Obulytix, a spin-off based on research results from Ghent University and KU Leuven, has built a platform that creates new ways to tackle bacterial infections. The phage lysin-based platform – using artificial intelligence (AI) – has attracted a significant €4 million investment from Boehringer Ingelheim Venture Fund, Qbic, and Gemma… Read More

#Business & Investment #News #Start-up Zone

Bacteria
#Antibiotics #Antimicrobial resistance (AMR) #Funding #Glox Therapeutics #University of Glasgow #University of Oxford

University spin-out secures £4.3M to develop precision antibiotics

Glox Therapeutics has raised £4.3M ($5.2M) in seed funding to develop targeted therapeutics against antibiotic-resistant Gram-negative bacteria. The company will use the funding to establish laboratories in Oxford and Glasgow and expand its team to accelerate its bacteriocin development programme. Glox Therapeutics is developing precision antibiotics using engineered protein bacteriocins. Read More

#Business & Investment #News #Trending News

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Funding

£30m initiative will support early-stage antimicrobial development

A partnership has been set up to promote the development of new treatments to tackle the global threat of antimicrobial resistance (AMR). Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 ($36) million initiative… Read More

#News #Trending News

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Molecular Biology

The inner workings of antibiotics

Listen to this article on the DDW Podcast: Dr Luke Clifton, Instrument Scientist at ISIS Neutron and Muon Source, explains the molecular mechanism behind antibiotics. Since the initial large-scale production and widespread use of antibiotics in the 1940s there has been a continual race between the development of antibiotics and bacterial… Read More

#Exclusive Content

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Drug discovery

Antimicrobial resistance: Tackling the ‘silent pandemic’

Diana Spencer speaks to Christopher Reid, Professor of Biological and Biomedical Sciences at Bryant University, in Rhode Island, US, to understand the issue of antimicrobial resistance, why there are so few new antibiotics in development and where the drug discovery opportunities can be found. The scale of the crisis In… Read More

#Exclusive Content

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria

Powerful new antibiotic isolated from microbial ‘dark matter’

New powerful antibiotic Clovibactin seems capable of combating harmful bacteria, and even multi-resistant ‘superbugs’, in a way that makes it more difficult for bacteria to develop resistance against it.   Researchers from Utrecht University (Netherlands), Bonn University (Germany), the German Center for Infection Research (DZIF), Northeastern University of… Read More

#News #Trending News

Bacteria
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bugworks Research #Global Antibiotic Research & Development Partnership

Partners collaborate on new broad-spectrum antibiotic

The Global Antibiotic Research & Development Partnership (GARDP) is joining forces with Indian biopharmaceutical company Bugworks Research to accelerate the development of a new broad-spectrum antibiotic compound. The compound being developed by Bugworks, BWC0977, is aimed at treating patients with serious bacterial infections in both critical… Read More

#News

Antibiotics
#AMR #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Immunology / Virology & Vaccines #University of Queensland

Global crisis of antibiotic resistance is “inevitable”

A report by University of Queensland (UQ) researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics. The Centre for Superbug Solutions at UQ’s Institute for Molecular Bioscience has monitored the clinical pipeline for more than a decade, with… Read More

#Editor's Choice #News

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Covid-19 #Gut microbiome

Severe Covid-19 linked to antibiotics overuse

Frequent and diverse use of antibiotics may be associated with developing more severe outcomes after a Covid-19 infection, including death, UK scientists have shown. The findings, funded by Health Data Research UK and the National Institute for Health and Care Research (NIHR), act as a warning… Read More

#Editor's Choice #News

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #University of Gothenburg

Study identifies previously unknown antibiotic resistance genes

Genes that make bacteria resistant to antibiotics are much more widespread in our environment than was previously realised. A new study, from Chalmers University of Technology and the University of Gothenburg in Sweden, shows that bacteria in almost all environments carry resistance genes. “We… Read More

#News

Antibiotics
#ABPI #Antibiotics #Antimicrobial resistance (AMR) #Investment #UK government

UK government invests £39 million in AMR research

The UK government will invest up to £39 ($48) million in antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF). The funding includes up to £25 ($30.9) million awarded to support the early development of new antibiotics, vaccines, rapid diagnostics and other products to… Read More

#Editor's Choice #News

#Antibiotics #Cancer vaccine #Drug discovery #HIV #Long Covid #Malaria

This week in drug discovery (10-14 April)

News round-up for 10-14 April by DDW Digital Content Editor Diana Spencer. The headlines getting our attention this week all represent significant breakthroughs in the treatment of various diseases and could make a huge difference to the lives of these patients. Perhaps most significantly,… Read More

#News